Abstract
Interleukin (IL)-12 may be secreted as a bioactive T helper type 1 (Th1) cell–inducing heterodimer, as a monomer, or as an antagonistic homodimer. We analyzed the IL-12 produced by mouse splenic dendritic cells (DCs), human thymic DCs, and cultured human monocyte-derived DCs. IL-12 production required both a microbial or T cell–derived stimulus and an appropriate cytokine milieu. The different IL-12 forms were differentially regulated by the cytokines present rather than the stimulus used. IL-4 alone or together with granulocyte/macrophage colony-stimulating factor or interferon γ effectively enhanced the production of the bioactive heterodimer and selectively reduced the antagonistic homodimer of IL-12. Therefore, IL-4, the major Th2-driving cytokine, provides a negative feedback causing DCs to produce the major Th1-inducing cytokine, bioactive IL-12.
Bibliography
Hochrein, H., OâKeeffe, M., Luft, T., Vandenabeele, S., Grumont, R. J., Maraskovsky, E., & Shortman, K. (2000). Interleukin (Il)-4 Is a Major Regulatory Cytokine Governing Bioactive IL-12 Production by Mouse and Human Dendritic Cells. The Journal of Experimental Medicine, 192(6), 823â834.
References
52
Referenced
297
10.1084/jem.170.3.827
/ J. Exp. Med. / Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes by Kobayashi (1989)10.4049/jimmunol.146.9.3074
/ J. Immunol / Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells by Wolf (1991)10.1073/pnas.88.10.4143
/ Proc. Natl. Acad. Sci. USA. / Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor by Gubler (1991)10.1016/S0065-2776(08)60387-9
/ Adv. Immunol. / Interleukin-12a cytokine at the interface of inflammation and immunity by Trinchieri (1998)10.1146/annurev.immunol.16.1.495
/ Annu. Rev. Immunol. / The interleukin-12/interleukin-12-receptor systemrole in normal and pathologic immune responses by Gately (1998)10.1084/jem.176.5.1387
/ J. Exp. Med. / Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells by D'Andrea (1992)10.4049/jimmunol.158.9.4381
/ J. Immunol. / In vivo production and function of IL-12 p40 homodimers by Heinzel (1997)10.1002/eji.1830250133
/ Eur. J. Immunol. / Mouse interleukin-12 (IL-12) p40 homodimera potent IL-12 antagonist by Gillessen (1995)10.4049/jimmunol.154.1.116
/ J. Immunol. / Human IL-12 p40 homodimer binds to the IL-12 receptor but does not mediate biologic activity by Ling (1995)10.1002/eji.1830230923
/ Eur. J. Immunol. / The interleukin-12 subunit p40 specifically inhibits effects of the interleukin-12 heterodimer by Mattner (1993)10.1007/s001250050728
/ Diabetologia / Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2 by Rothe (1997)10.1128/iai.65.11.4734-4737.1997
/ Infect. Immun. / Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor alpha-dependent shock by Mattner (1997)10.1111/j.1749-6632.1996.tb52650.x
/ Ann. NY Acad. Sci. / Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo by Gately (1996)10.1073/pnas.93.17.9085
/ Proc. Natl. Acad. Sci. USA. / Local production of the p40 subunit of interleukin 12 suppresses T-helper 1-mediated immune responses and prevents allogeneic myoblast rejection by Kato (1996)10.1172/JCI2675
/ J. Clin. Invest. / Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice by Yasuda (1998)10.4049/jimmunol.160.2.588
/ J. Immunol. / Reduced T helper 1 responses in IL-12 p40 transgenic mice by Yoshimoto (1998)10.1002/(SICI)1097-0215(19980729)77:3<460::AID-IJC24>3.0.CO;2-A
/ Int. J. Cancer. / Increased IL-12 P40 homodimer secretion by spleen cells during in vivo growth of the BW-19 T cell hybridoma accompanies suppression of natural immunity by Schmidt (1998)10.4049/jimmunol.154.10.5071
/ J. Immunol. / Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells by Macatonia (1995)10.1002/eji.1830260323
/ Eur. J. Immunol. / Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells by Heufler (1996)10.1084/jem.184.2.741
/ J. Exp. Med. / High level IL-12 production by murine dendritic cellsupregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 by Koch (1996)10.1084/jem.184.2.747
/ J. Exp. Med. / Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacityT–T help via APC activation by Cella (1996)10.4049/jimmunol.158.6.2919
/ J. Immunol. / Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cellsevidence for a soluble CD14-dependent pathway by Verhasselt (1997)10.1182/blood.V83.7.1847.1847
/ Blood. / Differential regulation of interleukin-12 (IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells by Kubin (1994)10.1182/blood.V86.2.646.bloodjournal862646
/ Blood. / Regulation of interleukin-12 expression in human monocytesselective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes by Hayes (1995)10.4049/jimmunol.159.1.28
/ J. Immunol. / IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T helper cells by Kalinski (1997)10.1084/jem.181.2.537
/ J. Exp. Med. / Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cellspriming for IL-12 and tumor necrosis factor alpha production by D'Andrea (1995)10.4049/jimmunol.151.11.6370
/ J. Immunol. / Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN- gamma or IL-10 by de Waal Malefyt (1993)10.4049/jimmunol.159.11.5705
/ J. Immunol. / Priming with IL-4 and IL-13 during HIV-1 infection restores in vitro IL-12 production by mononuclear cells of HIV-infected patients by Marshall (1997)10.4049/jimmunol.156.3.1207
/ J. Immunol. / Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit by Snijders (1996)10.1046/j.1365-2567.1999.00711.x
/ Immunology. / Interleukin-4 regulation of human monocyte and macrophage interleukin-10 and interleukin-12 production. Role of a functional interleukin-2 receptor gamma-chain by Bonder (1999)10.4049/jimmunol.156.3.1196
/ J. Immunol. / Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines by Skeen (1996)10.1002/jlb.61.1.80
/ J. Leukoc. Biol. / Regulation of T cell-dependent and -independent IL-12 production by the three Th2-type cytokines IL-10, IL-6, and IL-4 by Takenaka (1997)10.1038/386336a0
/ Nature. / Bacterial DNA causes septic shock by Sparwasser (1997)10.1084/jem.176.1.47
/ J. Exp. Med. / The surface phenotype of dendritic cells purified from mouse thymus and spleeninvestigation of the CD8 expression by a subpopulation of dendritic cells by Vremec (1992)10.4049/jimmunol.159.2.565
/ J. Immunol. / Dendritic cell subtypes in mouse lymphoid organscross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes by Vremec (1997)10.1002/eji.1830260606
/ Eur. J. Immunol. / Structure and chromosomal location of the mouse interleukin-12 p35 and p40 subunit genes by Tone (1996)10.1093/nar/12.18.6951
/ Nucleic Acids Res. / Post-transcriptional regulation of glyceraldehyde 3-phosphate-dehydrogenase gene expression in rat tissues by Piechaczyk (1984)10.1084/jem.184.5.1953
/ J. Exp. Med. / Dramatic increase in the numbers of functionally mature dendritic cells in mice treated with Flt3 ligandmultiple dendritic cell subpopulations identified by Maraskovsky (1996)10.4049/jimmunol.164.6.2978
/ J. Immunol. / CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen by Vremec (2000)10.1073/pnas.96.3.1036
/ Proc. Natl. Acad. Sci. USA. / Distinct dendritic cell subsets differentially regulate the class of immune response in vivo by Pulendran (1999)10.1084/jem.186.11.1819
/ J. Exp. Med. / In vivo microbial stimulation induces rapid CD40 ligand–independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas by Sousa (1997)10.1084/jem.189.3.587
/ J. Exp. Med. / CD8α1 and CD8α− subclasses of dendritic cells direct the development of distinct T helper cells in vivo by Maldonado-Lopez (1999)10.4049/jimmunol.164.1.64
/ J. Immunol. / Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells by Fukao (2000)10.4049/jimmunol.157.5.2209
/ J. Immunol. / Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats by Ramanathan (1996)10.1084/jem.187.3.307
/ J. Exp. Med. / Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans by Mencacci (1998)10.1084/jem.169.1.59
/ J. Exp. Med. / Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets by Heinzel (1989)10.1084/jem.188.8.1547
/ J. Exp. Med. / Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin–derived dendritic cellsimplications for the initiation of anti-Leishmania immunity by von Stebut (1998)10.1002/eji.1830260722
/ Eur. J. Immunol. / Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response by Mattner (1996)10.1002/(SICI)1521-4141(199802)28:02<687::AID-IMMU687>3.0.CO;2-N
/ Eur. J. Immunol. / Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection by Gorak (1998)10.4049/jimmunol.162.2.974
/ J. Immunol. / Anti-TGF-beta treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production by Li (1999)10.4049/jimmunol.159.10.5024
/ J. Immunol. / Leishmania major-infected C3H mice treated with anti-IL-12 mAb develop but do not maintain a Th2 response by Hondowicz (1997)10.4049/jimmunol.160.8.3627
/ J. Immunol. / CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis by Zimmermann (1998)
Dates
Type | When |
---|---|
Created | 23 years, 1 month ago (July 26, 2002, 12:48 p.m.) |
Deposited | 2 years, 1 month ago (July 25, 2023, 6:41 a.m.) |
Indexed | 4 months, 3 weeks ago (April 9, 2025, 2:02 a.m.) |
Issued | 24 years, 11 months ago (Sept. 11, 2000) |
Published | 24 years, 11 months ago (Sept. 11, 2000) |
Published Online | 24 years, 11 months ago (Sept. 11, 2000) |
Published Print | 24 years, 11 months ago (Sept. 18, 2000) |
@article{Hochrein_2000, title={Interleukin (Il)-4 Is a Major Regulatory Cytokine Governing Bioactive IL-12 Production by Mouse and Human Dendritic Cells}, volume={192}, ISSN={1540-9538}, url={http://dx.doi.org/10.1084/jem.192.6.823}, DOI={10.1084/jem.192.6.823}, number={6}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Hochrein, Hubertus and O’Keeffe, Meredith and Luft, Thomas and Vandenabeele, Stéphane and Grumont, Raelene J. and Maraskovsky, Eugene and Shortman, Ken}, year={2000}, month=sep, pages={823–834} }